Page last updated: 2024-08-24

5-methylcytosine and Melanoma

5-methylcytosine has been researched along with Melanoma in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19902 (8.70)18.7374
1990's0 (0.00)18.2507
2000's1 (4.35)29.6817
2010's18 (78.26)24.3611
2020's2 (8.70)2.80

Authors

AuthorsStudies
Gruis, N; Janssen, B; Kumar, R; Oosting, J; Salgado, C; van Doorn, R1
Balzer, BL; Frishberg, DP; Shon, W; Yagi, S1
Barciszewska, AM1
Balzer, BL; Essner, R; Frishberg, DP; Huynh, CAT; Shon, W; Siref, AB1
Chen, Y; Sugiyama, T1
Gambichler, T; Sand, M; Skrygan, M1
Ashida, A; Hayashi, K; Kiniwa, Y; Koga, H; Ogawa, E; Okuyama, R; Takazawa, Y; Uchiyama, A; Uchiyama, R; Uhara, H1
Adany, R; Balazs, M; Ecsedi, SI; Herceg, Z; Hernandez-Vargas, H; Lima, SC1
Dresser, KA; Larson, AR; Lezcano, C; Lian, CG; Mihm, MC; Murphy, GF; Scolyer, RA; Shi, YG; Thompson, JF; Woda, BA; Yosufi, B; Zhan, Q1
Granter, SR; Guo, W; Laga, AC; Lee, JJ; Lian, CG; Murphy, GF; Saavedra, AP; Xu, S; Zhan, Q1
Burns, KH; Rodić, N; Sharma, R; Taube, JM; Zampella, J1
Cook, M; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Wang, TJ; Xu, S; Zhan, Q1
Fraitag, S; Hohl, D; Pavlova, O1
Bamford, M; Joshi, K; Lawes, K; Moosa, F; Pringle, JH; Saldanha, G; Teo, KW1
Chen, L; Gong, F; Guo, Y; Jin, J; Li, R; Ma, RZ; Niu, Y; Shi, X; Zhang, L; Zhang, X1
Bosenberg, MW; Micevic, G; Rodić, N; Taube, JM; Theodosakis, N1
Fang, S; Huff, C; Lee, JE; Shen, J; Song, R; Wan, J; Zhao, H1
Bresler, SC; Fletcher, CD; Frank, AH; Granter, SR; Hu, NR; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Saw, RP; Scolyer, RA; Vilain, RE; Xu, S1
Hu, G; Jiang, MJ; Li, FJ; Li, LM; Long, J; Xu, C; Zhang, RH; Zhou, P1
Ceol, C; Dresser, K; Duncan, LM; Fang, R; Houvras, Y; Hu, D; Hu, Y; Kaiser, UB; Kakavand, H; Khorasani, AJ; Kleffel, S; Larson, A; Lee, CW; Lezcano, C; Lian, BQ; Lian, CG; Mihm, MC; Murphy, GF; Neiswender, J; Schatton, T; Scolyer, RA; Shi, YG; Tan, L; Thompson, JF; Woda, BA; Wu, F; Xu, W; Xu, Y; Yang, Y; Zhan, Q; Zon, LI1
Besaratinia, A; Pfeifer, GP; You, YH1
Everett, CA; Finch, M; Hart, IR; Ormerod, EJ1
Kerbel, RS; Liteplo, RG1

Reviews

2 review(s) available for 5-methylcytosine and Melanoma

ArticleYear
The role of 5-hydroxymethylcytosine in melanoma.
    Melanoma research, 2017, Volume: 27, Issue:3

    Topics: 5-Methylcytosine; DNA Methylation; Epigenesis, Genetic; Humans; Melanoma

2017
Mutations induced by ultraviolet light.
    Mutation research, 2005, Apr-01, Volume: 571, Issue:1-2

    Topics: 5-Methylcytosine; Animals; Humans; Melanoma; Mutation; Neoplasms, Radiation-Induced; Pyrimidine Dimers; Skin Neoplasms; Ultraviolet Rays

2005

Other Studies

21 other study(ies) available for 5-methylcytosine and Melanoma

ArticleYear
Genome-wide characterization of 5-hydoxymethylcytosine in melanoma reveals major differences with nevus.
    Genes, chromosomes & cancer, 2020, Volume: 59, Issue:6

    Topics: 5-Methylcytosine; 5' Untranslated Regions; Adult; Biomarkers, Tumor; CpG Islands; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus

2020
Epigenetic marker expression is of limited diagnostic utility in spitzoid melanocytic neoplasms.
    Journal of cutaneous pathology, 2020, Volume: 47, Issue:12

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Epigenesis, Genetic; Female; Humans; Male; Melanoma; Nevus, Epithelioid and Spindle Cell; Skin Neoplasms

2020
Global DNA demethylation as an epigenetic marker of human brain metastases.
    Bioscience reports, 2018, 10-31, Volume: 38, Issue:5

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; DNA Demethylation; DNA Methylation; Epigenesis, Genetic; Humans; Melanoma; Prognosis

2018
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
    Journal of cutaneous pathology, 2019, Volume: 46, Issue:4

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Humans; Immunohistochemistry; Lymphatic Metastasis; MART-1 Antigen; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Skin Neoplasms; Staining and Labeling

2019
Biochemical reconstitution of UV-induced mutational processes.
    Nucleic acids research, 2019, 07-26, Volume: 47, Issue:13

    Topics: 5-Methylcytosine; Cell-Free System; Cytosine; Deamination; DNA Damage; DNA Replication; DNA-Cytosine Methylases; DNA-Directed DNA Polymerase; DNA, Neoplasm; DNA, Single-Stranded; Humans; Melanoma; Models, Genetic; Mutagenesis; Neoplasms, Radiation-Induced; Pyrimidine Dimers; Skin Neoplasms; Transcriptome; Ultraviolet Rays

2019
Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma.
    Melanoma research, 2013, Volume: 23, Issue:3

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Cytosine; Dioxygenases; Disease Progression; DNA-Binding Proteins; Epigenomics; Humans; Melanoma; Paraffin Embedding; Proto-Oncogene Proteins; Skin Neoplasms; Translocation, Genetic

2013
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
    Journal of dermatological science, 2014, Volume: 73, Issue:2

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers; CpG Islands; Cytosine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Keratinocytes; Male; Melanoma; Middle Aged; Nevus, Epithelioid and Spindle Cell; Nevus, Pigmented; Skin Neoplasms

2014
Transposable hypomethylation is associated with metastatic capacity of primary melanomas.
    International journal of clinical and experimental pathology, 2013, Volume: 6, Issue:12

    Topics: 5-Methylcytosine; Adult; CpG Islands; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Transposable Elements; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; Long Interspersed Nucleotide Elements; Male; Melanoma; Middle Aged; Phenotype; Proportional Hazards Models; Risk Factors; Skin Neoplasms; Time Factors; Treatment Outcome; Young Adult

2013
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2014, Volume: 27, Issue:7

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus; Precancerous Conditions; Skin Neoplasms; Young Adult

2014
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2015, Volume: 28, Issue:2

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cytosine; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nevus; Sentinel Lymph Node Biopsy; Skin Neoplasms

2015
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
    Journal of cutaneous pathology, 2015, Volume: 42, Issue:11

    Topics: 5-Methylcytosine; Cytosine; Diagnosis, Differential; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Melanocytes; Melanoma; Nevus, Pigmented; Skin Neoplasms; Tissue Array Analysis

2015
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
    Oncotarget, 2015, Nov-10, Volume: 6, Issue:35

    Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Small Cell; Cytosine; Epigenomics; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Nevus, Pigmented; Prognosis; Skin Neoplasms; Young Adult

2015
5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:12

    Topics: 5-Methylcytosine; Adult; Analysis of Variance; Biopsy, Needle; Cohort Studies; Diagnosis, Differential; Disease Progression; Dysplastic Nevus Syndrome; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Skin Neoplasms

2016
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2017, Volume: 30, Issue:1

    Topics: 5-Methylcytosine; Age Factors; Aged; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Skin; Skin Neoplasms; Survival Rate

2017
Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Oncotarget, 2017, Jan-03, Volume: 8, Issue:1

    Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Line, Tumor; Chromatin Immunoprecipitation; Decitabine; Dioxygenases; Disease Progression; DNA (Cytosine-5-)-Methyltransferases; DNA Demethylation; DNA Methylation; DNA Methyltransferase 3A; DNA-Binding Proteins; Down-Regulation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Promoter Regions, Genetic; Proto-Oncogene Proteins; RNA, Small Interfering; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays

2017
Attenuation of genome-wide 5-methylcytosine level is an epigenetic feature of cutaneous malignant melanomas.
    Melanoma research, 2017, Volume: 27, Issue:2

    Topics: 5-Methylcytosine; Apoptosis; Cell Line, Tumor; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Genome; Humans; Melanoma; Nevus, Pigmented; S-Adenosylmethionine; Skin Neoplasms

2017
Global methylation of blood leukocyte DNA and risk of melanoma.
    International journal of cancer, 2017, 04-01, Volume: 140, Issue:7

    Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; Case-Control Studies; DNA Methylation; Female; Genetic Predisposition to Disease; Humans; Leukocytes; Male; Melanoma; Middle Aged; Odds Ratio; Phenotype; Risk Factors; Skin Neoplasms; Skin Pigmentation; Sunlight

2017
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
    Journal of cutaneous pathology, 2017, Volume: 44, Issue:3

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cohort Studies; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Nevus, Pigmented; Retrospective Studies; Skin Neoplasms; Young Adult

2017
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
    Cell, 2012, Sep-14, Volume: 150, Issue:6

    Topics: 5-Methylcytosine; Cytosine; Dioxygenases; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Isocitrate Dehydrogenase; Melanocytes; Melanoma; Nevus; Proto-Oncogene Proteins

2012
DNA methylation levels in human and murine melanoma cell lines of varying metastatic potential.
    Cancer research, 1986, Volume: 46, Issue:9

    Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Line; Cytosine; DNA, Neoplasm; Humans; Melanoma; Methylation; Mice; Neoplasm Metastasis

1986
Reduced levels of DNA 5-methylcytosine in metastatic variants of the human melanoma cell line MeWo.
    Cancer research, 1987, May-01, Volume: 47, Issue:9

    Topics: 5-Methylcytosine; Animals; Cell Line; Chromatography, High Pressure Liquid; Cytosine; DNA; Humans; Hydrolysis; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Uridine

1987